• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤药物产品的食物效应研究。

Food Effect Studies for Oncology Drug Products.

作者信息

Parsad S, Ratain M J

机构信息

University of Chicago Medicine, Chicago, Illinois, USA.

University of Chicago, Chicago, Illinois, USA.

出版信息

Clin Pharmacol Ther. 2017 May;101(5):606-612. doi: 10.1002/cpt.610. Epub 2017 Mar 20.

DOI:10.1002/cpt.610
PMID:28073144
Abstract

Oral antineoplastic agents provide convenience to the patient, but are accompanied by challenges distinct from parenteral cancer treatment. Challenges include a more complex pharmacokinetic profile, with food influencing the absorption of many agents. Standards for evaluating and labeling prandial implications on oral chemotherapy are inconsistent; studies to determine food effects should be conducted early, and potentially often, during drug development with standardization on how rational fasting or fed recommendations are presented in the package insert (PI).

摘要

口服抗肿瘤药物为患者提供了便利,但也伴随着与肠胃外癌症治疗不同的挑战。挑战包括更复杂的药代动力学特征,食物会影响许多药物的吸收。评估和标注口服化疗的餐食影响的标准并不一致;在药物研发过程中,应尽早且可能经常进行确定食物影响的研究,并对如何在药品说明书(PI)中合理呈现禁食或进食建议进行标准化。

相似文献

1
Food Effect Studies for Oncology Drug Products.肿瘤药物产品的食物效应研究。
Clin Pharmacol Ther. 2017 May;101(5):606-612. doi: 10.1002/cpt.610. Epub 2017 Mar 20.
2
Food and oral antineoplastics: more than meets the eye.口服抗肿瘤药物与食物:比想象中更复杂。
Clin Cancer Res. 2010 Sep 1;16(17):4305-7. doi: 10.1158/1078-0432.CCR-10-1857. Epub 2010 Aug 24.
3
Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.不同治疗领域的口服药物食品效应标签不一致:肿瘤学产品与非肿瘤学产品之间的差异。
Clin Cancer Res. 2010 Sep 1;16(17):4446-51. doi: 10.1158/1078-0432.CCR-10-0663. Epub 2010 Aug 24.
4
Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.食物对抗癌药物临床药代动力学的影响:潜在机制及对口服化疗的意义。
Clin Pharmacokinet. 2004;43(15):1127-56. doi: 10.2165/00003088-200443150-00005.
5
Impact of dosage timing on the bioavailability of oral anticancer medications: Is pre-prandial dosing equivalent to post-prandial dosing.给药时间对口服抗癌药物生物利用度的影响:餐前给药等同于餐后给药吗?
J Oncol Pharm Pract. 2019 Mar;25(2):404-408. doi: 10.1177/1078155217752535. Epub 2018 Jan 17.
6
Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors.食物和抑酸剂对实体瘤口服靶向治疗药物吸收的影响。
Drug Discov Today. 2016 Jun;21(6):962-76. doi: 10.1016/j.drudis.2016.03.002. Epub 2016 Mar 17.
7
Fed or fasted state for oral therapies in breast cancer treatment? A comprehensive review of clinical practice recommendations.口服治疗乳腺癌时应选择进食还是禁食状态?临床实践推荐的综合综述。
Cancer Treat Rev. 2021 Nov;100:102281. doi: 10.1016/j.ctrv.2021.102281. Epub 2021 Aug 18.
8
To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs.是否随餐服用?解析口服抗肿瘤药物食物影响标签相关问题
Clin Pharmacol Drug Dev. 2018 Jun;7(5):455-464. doi: 10.1002/cpdd.416. Epub 2017 Dec 2.
9
Oral chemotherapy food and drug interactions: a comprehensive review of the literature.口服化疗药物与食物和药物的相互作用:文献综述
J Oncol Pract. 2014 Jul;10(4):e255-68. doi: 10.1200/JOP.2013.001183. Epub 2014 Apr 22.
10
Flushing oral oncology drugs down the toilet.将口腔肿瘤药物冲进马桶。
J Clin Oncol. 2011 Oct 20;29(30):3958-9. doi: 10.1200/JCO.2011.37.1617. Epub 2011 Sep 19.

引用本文的文献

1
Consideration on Food Effect Studies for Anticancer Drugs Approved in Japan Between 2001 and 2022.对2001年至2022年在日本获批的抗癌药物的食物效应研究的思考
Clin Transl Sci. 2025 Jul;18(7):e70304. doi: 10.1111/cts.70304.
2
A randomized, open-label, two-period crossover study to evaluate the bioequivalence and food effect between two formulations of regorafenib in healthy adult participants.一项随机、开放标签、两阶段交叉研究,旨在评估健康成年受试者中瑞戈非尼两种制剂之间的生物等效性和食物影响。
Front Pharmacol. 2025 Mar 19;16:1511558. doi: 10.3389/fphar.2025.1511558. eCollection 2025.
3
A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy.
美国食品药品监督管理局(FDA)批准的用于脑肿瘤治疗的多靶点血管生成药物综述。
Int J Mol Sci. 2025 Feb 28;26(5):2192. doi: 10.3390/ijms26052192.
4
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.食物和种族对新型 PARP 抑制剂维奈妥拉在健康韩国、白种人和中国男性受试者中的药代动力学的影响。
Invest New Drugs. 2024 Feb;42(1):80-88. doi: 10.1007/s10637-023-01405-z. Epub 2023 Dec 15.
5
The use of microtracers in food-effect trials: An alternative study design for toxic drugs with long half-lives exemplified by the case for alectinib.微示踪剂在食物效应试验中的应用:以阿来替尼为例的长半衰期毒药物的替代研究设计。
Clin Transl Sci. 2023 Dec;16(12):2557-2564. doi: 10.1111/cts.13647. Epub 2023 Oct 12.
6
Bioequivalence and Pharmacokinetic Evaluation of Two Oral Formulations of Regorafenib: An Open-Label, Randomised, Single-Dose, Two-Period, Two-Way Crossover Clinical Trial in Healthy Chinese Volunteers Under Fasting and Fed Conditions.两种瑞戈非尼口服制剂的生物等效性和药代动力学评价:在健康中国志愿者中进行的禁食和进食条件下的单次、开放标签、随机、两周期、两交叉临床试验。
Drug Des Devel Ther. 2021 Jul 29;15:3277-3288. doi: 10.2147/DDDT.S323169. eCollection 2021.
7
Effect of Food on the Pharmacokinetics of Quizartinib.食物对 Quizartinib 药代动力学的影响。
Clin Pharmacol Drug Dev. 2020 Feb;9(2):277-286. doi: 10.1002/cpdd.770. Epub 2020 Jan 8.
8
Relationship between the effects of food on the pharmacokinetics of oral antineoplastic drugs and their physicochemical properties.食物对口服抗肿瘤药物药代动力学的影响与其理化性质之间的关系。
J Pharm Health Care Sci. 2019 Dec 3;5:26. doi: 10.1186/s40780-019-0155-1. eCollection 2019.
9
Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520.随机、开放标签、交叉研究评估食物和液体配方对新型黏着斑激酶(FAK)抑制剂 BI 853520 药代动力学的影响。
Target Oncol. 2019 Feb;14(1):67-74. doi: 10.1007/s11523-018-00618-0.
10
Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.美国食品药品监督管理局对2011 - 2017年批准的肿瘤学新分子实体的反向翻译:抗癌药物开发的经验教训
Clin Transl Sci. 2018 Mar;11(2):123-146. doi: 10.1111/cts.12527. Epub 2017 Dec 19.